Cardiol Therapeutics (CRDL) Return on Equity [ROE] (2021 - 2026)
Cardiol Therapeutics (CRDL) recorded Return on Equity [ROE] of -148.54% in Q2 2026, up 17.62 percentage points from the prior quarter.
Powered by 
Analysis
Cardiol Therapeutics (CRDL) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Cardiol Therapeutics reported Return on Equity [ROE] of -159.84%, down 20.97 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for three straight years, with a four-year change of -87.94 percentage points (FY2021 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -138.86% in FY2024 (-69.22 pp), -69.64% in FY2023 (-21.26 pp), -48.38% in FY2022 (+23.51 pp) and -71.90% in FY2021.
- The Q2 2026 figure is the highest quarterly Return on Equity [ROE] since Q1 2024.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 40.30 percentage points in Q2 2023, against a drop of 147.87 percentage points in Q2 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Cardiol Therapeutics | 102.26 Mn | 40.05 Mn | - | -148.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -148.54% |
| Mar 31, 2026 | -166.16% |
| Dec 31, 2025 | -241.43% |
| Jun 30, 2024 | -171.23% |
| Mar 31, 2024 | -117.00% |
| Dec 31, 2023 | -31.41% |
| Sep 30, 2023 | -19.24% |
| Jun 30, 2023 | -23.36% |
| Mar 31, 2023 | -38.67% |
| Dec 31, 2022 | -42.30% |
| Sep 30, 2022 | -44.77% |
| Jun 30, 2022 | -63.66% |
| Mar 31, 2022 | -54.29% |
| Dec 31, 2021 | -47.14% |
| Sep 30, 2021 | -39.73% |
| Jun 30, 2021 | -37.40% |
| Mar 31, 2021 | -63.37% |
API Access
Cardiol Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRDL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CRDL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRDL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();